Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Allyl Compounds | 7 | 2014 | 47 | 1.630 |
Why?
|
| Disulfides | 2 | 2014 | 77 | 0.900 |
Why?
|
| Benzo(a)pyrene | 3 | 2012 | 122 | 0.870 |
Why?
|
| Sulfides | 5 | 2012 | 58 | 0.720 |
Why?
|
| Carcinogens | 5 | 2012 | 117 | 0.550 |
Why?
|
| Hepatocytes | 2 | 2011 | 74 | 0.480 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 82 | 0.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 325 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 166 | 0.390 |
Why?
|
| Cell Cycle | 7 | 2012 | 309 | 0.390 |
Why?
|
| Acetylcysteine | 1 | 2010 | 58 | 0.380 |
Why?
|
| Plant Extracts | 1 | 2012 | 250 | 0.360 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 756 | 0.350 |
Why?
|
| Anticarcinogenic Agents | 4 | 2008 | 65 | 0.300 |
Why?
|
| Cell Survival | 6 | 2012 | 818 | 0.290 |
Why?
|
| Apoptosis | 6 | 2014 | 1317 | 0.280 |
Why?
|
| Garlic | 2 | 2014 | 31 | 0.240 |
Why?
|
| Breast | 3 | 2008 | 134 | 0.210 |
Why?
|
| Cell Proliferation | 5 | 2014 | 1149 | 0.200 |
Why?
|
| Cadmium | 2 | 2011 | 56 | 0.200 |
Why?
|
| DNA Damage | 3 | 2012 | 341 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2012 | 2128 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 160 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2008 | 34 | 0.160 |
Why?
|
| Rats | 8 | 2011 | 3261 | 0.140 |
Why?
|
| Cell Line | 5 | 2011 | 1289 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2012 | 392 | 0.130 |
Why?
|
| Chemoprevention | 2 | 2012 | 34 | 0.130 |
Why?
|
| Comet Assay | 2 | 2012 | 72 | 0.130 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 26 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 445 | 0.130 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.120 |
Why?
|
| Glutathione Reductase | 2 | 2011 | 22 | 0.120 |
Why?
|
| Catalase | 2 | 2011 | 106 | 0.120 |
Why?
|
| Glutathione Peroxidase | 2 | 2011 | 109 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 480 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 71 | 0.110 |
Why?
|
| Succimer | 1 | 2011 | 6 | 0.100 |
Why?
|
| Chelating Agents | 1 | 2011 | 53 | 0.100 |
Why?
|
| Diethylstilbestrol | 2 | 2006 | 6 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 416 | 0.090 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2010 | 28 | 0.090 |
Why?
|
| Imidazoles | 2 | 2008 | 124 | 0.090 |
Why?
|
| Herbicides | 1 | 2010 | 44 | 0.090 |
Why?
|
| Artemia | 1 | 2009 | 14 | 0.090 |
Why?
|
| Pyrrolidines | 1 | 2009 | 26 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 166 | 0.090 |
Why?
|
| Piperidines | 1 | 2009 | 76 | 0.090 |
Why?
|
| Stilbenes | 1 | 2009 | 41 | 0.090 |
Why?
|
| Humans | 8 | 2014 | 34853 | 0.080 |
Why?
|
| Glucose | 1 | 2010 | 217 | 0.080 |
Why?
|
| Astrocytes | 1 | 2010 | 203 | 0.080 |
Why?
|
| Animals | 9 | 2011 | 14307 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 386 | 0.080 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 10 | 0.080 |
Why?
|
| DNA Breaks | 1 | 2007 | 4 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 1426 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 239 | 0.080 |
Why?
|
| Cocaine | 1 | 2009 | 219 | 0.070 |
Why?
|
| Mitochondria | 1 | 2010 | 454 | 0.070 |
Why?
|
| Carcinoma | 1 | 2007 | 94 | 0.070 |
Why?
|
| DNA Repair | 1 | 2006 | 181 | 0.070 |
Why?
|
| Gliosis | 1 | 2004 | 22 | 0.070 |
Why?
|
| Apigenin | 1 | 2004 | 12 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2004 | 33 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 50 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 68 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 101 | 0.060 |
Why?
|
| Female | 6 | 2014 | 19873 | 0.060 |
Why?
|
| Microglia | 1 | 2004 | 152 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 137 | 0.060 |
Why?
|
| Methionine | 1 | 2002 | 28 | 0.060 |
Why?
|
| S-Adenosylmethionine | 1 | 2002 | 33 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 35 | 0.050 |
Why?
|
| Lung | 1 | 2005 | 413 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2005 | 366 | 0.050 |
Why?
|
| Cytokines | 1 | 2005 | 569 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 794 | 0.040 |
Why?
|
| G2 Phase | 2 | 2009 | 25 | 0.040 |
Why?
|
| Rats, Inbred ACI | 2 | 2006 | 10 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 2007 | 131 | 0.040 |
Why?
|
| Neurons | 1 | 2002 | 1130 | 0.030 |
Why?
|
| Brain | 1 | 2002 | 1268 | 0.030 |
Why?
|
| S Phase | 1 | 2011 | 36 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2010 | 33 | 0.020 |
Why?
|
| Vacuoles | 1 | 2009 | 22 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2009 | 13 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 160 | 0.020 |
Why?
|
| Biological Assay | 1 | 2009 | 56 | 0.020 |
Why?
|
| Larva | 1 | 2009 | 117 | 0.020 |
Why?
|
| Neuroglia | 1 | 2009 | 117 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 296 | 0.020 |
Why?
|
| Peroxides | 1 | 2007 | 20 | 0.020 |
Why?
|
| DNA Polymerase III | 1 | 2006 | 11 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2007 | 42 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2006 | 17 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 42 | 0.020 |
Why?
|
| DNA Adducts | 1 | 2006 | 41 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2006 | 43 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 447 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 83 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 49 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 149 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 260 | 0.020 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 2005 | 1 | 0.020 |
Why?
|
| Chemokine CCL24 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Receptors, CCR3 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Eosinophils | 1 | 2005 | 19 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2005 | 33 | 0.020 |
Why?
|
| Estrogens | 1 | 2006 | 190 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 24 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 18 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 21 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2005 | 69 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 126 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 287 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 200 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 220 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 1442 | 0.020 |
Why?
|
| DNA | 1 | 2007 | 549 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 112 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 44 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2002 | 84 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 859 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 72 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 59 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 91 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 490 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 72 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 139 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 968 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 229 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 352 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 5668 | 0.010 |
Why?
|
| Male | 1 | 2007 | 18870 | 0.010 |
Why?
|